© Kementerian Kesehatan RI
KFA Browser > Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (Umum)
| KFA Code (PV) | 93020242 |
| Type | Vaksin |
| Unit of Measure (UCUM) | milliliter |
| Smallest Logistic Unit | Vial |
| Dosage Form | Suspensi Injeksi |
| Drug Classification | Obat Keras |
| Route Administration | Intramuskular Injeksi (di dalam otot) |
| CVX Code | 212 |
| Vaccine Group | COVID-19 |
| CVX MVX Code | - |
| CVX Trade Name | - |
| NIE BPOM | - |
| Trade Name | - |
| Manufacturer | - |
| Registrar | - |
| Chemical Substance (INN) | J07BX03 - Covid-19 vaccines |
| Anatomical Main Group | J - ANTIINFECTIVES FOR SYSTEMIC USE |
| Therapectic Subgroup | J07 - VACCINES |
| Pharmacological Subgroup | J07B - VIRAL VACCINES |
| Chemical Subgroup | J07BX - Other viral vaccines |
| Alternative Name (USAN) | SARS-COV-2 (COVID-19) vaccine, vector - Ad26 |
| Kamus Farmalkes (KFA – IHS) | 93020242 - Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi |
| Name | Display Name | Dosage |
|---|---|---|
|
Sars-Cov-2 (Covid-19) Vaccine, Vector - Ad26 |
Sars-Cov-2 (Covid-19) Vaccine, Vector - Ad26 |
5 10*10/0.5 mL |
| KFA Code (PV) | Pack Type | Estimated Pack Price (IDR) |
|---|---|---|
| - | - | - |
